Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases

Serum alpha-fetoprotein (AFP) levels elevated in benign liver diseases (BLD) represent a challenge in hepatocellular carcinoma (HCC) diagnosis. The present study aimed to develop a simple method to identify HCC in AFP-elevated liver diseases based on combining serum fluorescence and general clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, Zhang, Kun-He, Hu, Piao-Ping, Wan, Qin-Si, Han, Fang-Li, Zhou, Jian-Ming, Huang, De-Qiang, Lv, Nong-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716689/
https://www.ncbi.nlm.nih.gov/pubmed/29228649
http://dx.doi.org/10.18632/oncotarget.22050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716689/
https://www.ncbi.nlm.nih.gov/pubmed/29228649
http://dx.doi.org/10.18632/oncotarget.22050

Ejemplares similares